Skip to Main Content
Contact Us
Image of people around a table for the Best Practices for Operationalizing Global, Early-Phase Oncology Trials webinar Best Practices for Operationalizing Global, Early-Phase Oncology Trials The early-phase oncology clinical trial landscape is constantly evolving, influenced by shifts in regulatory guidance Read Now Trends and Challenges Blog Series-Growing Complexity of Conducting Oncology Trials The Growing Complexity of Conducting Oncology Trials Changing regulations, challenging study designs, and globalization Early-phase trial designs are becoming more complex following Read Now Electronic Health Records to Electronic Data Capture Enhancing the Data Journey in Oncology Clinical Trials The choices made in clinical trial setup Read Now Journal of Clinical Studies thumbnail photo of a group of women speaking at a conference table. The Role of Company Culture in Functional Service Provider (FSP) Partnerships  Pharmaceutical and clinical research sponsors (clients) have long outsourced clinical development work, utilizing both full-service Read Now SCOPE 2025 Highlights Driving Efficiencies in Clinical Trials Catalyst Flex at SCOPE 2025 This year, I attended the SCOPE 2025 conference with key Read Now Driving Innovation in Radiopharmaceutical Therapies Oncology clinical research is complex, demanding, and continually evolving. Bringing effective radiopharmaceutical therapies from proof-of-concept Read Now Successful business people discussing regulations. A View of the Joint Clinical Assessment (JCA) Process An out-of-the-box solution to navigate regulation effectively The Joint Clinical Assessment (JCA) is a pivotal Read Now The Evolving Landscape of Oncology Drug Development Increasing incidence rates and the rise of novel therapies Oncology is the largest therapeutic area Read Now Graphic with words Catalyst Flex webinar with a professional sitting on the floor with creative, collaborative squiggles on the floor. Partnering with Functional Service Providers How culture drives success Consultants across industries suggest that a better corporate culture — one Read Now Breast cancer cells Developing Next-generation Therapies for Breast Cancer Patients Breast cancer is the second most common malignancy worldwide and the number one cancer in Read Now